KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Net Income towards Common Stockholders (2020 - 2025)

Historic Net Income towards Common Stockholders for Ginkgo Bioworks Holdings (DNA) over the last 6 years, with Q3 2025 value amounting to -$80.8 million.

  • Ginkgo Bioworks Holdings' Net Income towards Common Stockholders fell 4317.5% to -$80.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$339.5 million, marking a year-over-year increase of 4785.75%. This contributed to the annual value of -$547.0 million for FY2024, which is 3873.36% up from last year.
  • Per Ginkgo Bioworks Holdings' latest filing, its Net Income towards Common Stockholders stood at -$80.8 million for Q3 2025, which was down 4317.5% from -$60.3 million recorded in Q2 2025.
  • In the past 5 years, Ginkgo Bioworks Holdings' Net Income towards Common Stockholders registered a high of -$54.5 million during Q2 2021, and its lowest value of -$1.6 billion during Q4 2021.
  • For the 5-year period, Ginkgo Bioworks Holdings' Net Income towards Common Stockholders averaged around -$295.4 million, with its median value being -$173.1 million (2022).
  • In the last 5 years, Ginkgo Bioworks Holdings' Net Income towards Common Stockholders crashed by 335911.55% in 2021 and then skyrocketed by 8921.63% in 2022.
  • Ginkgo Bioworks Holdings' Net Income towards Common Stockholders (Quarter) stood at -$1.6 billion in 2021, then skyrocketed by 89.22% to -$173.1 million in 2022, then fell by 22.31% to -$211.7 million in 2023, then soared by 49.2% to -$107.5 million in 2024, then increased by 24.9% to -$80.8 million in 2025.
  • Its Net Income towards Common Stockholders stands at -$80.8 million for Q3 2025, versus -$60.3 million for Q2 2025 and -$91.0 million for Q1 2025.